Top member reports
No meetings
Consensus community valuation
The consensus valuation is for members only and has been removed from this chart. Click for membership options.
Contributing Members
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#FY24 MVF Results Presentation
Added 4 months ago

1b298e0b6c9c4b203ade6443fff5d504c0962e.png

Presentation Here: MONASH IVF GROUP LIMITED (ASX:MVF) - Ann: FY24 MVF Results Presentation, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum

2bd02d4e2061c2542a2d82c113f5f661aaaea5.png


Observation:

Earnings Have taken a Hit since 2018 ..Then the COVID flue dinted the clinical practitioners & Class action,

News Monash IVF Group's 'inaccurate' genetic test potentially robbed these women of viable embryos - ABC News

asx VRT 2022 was taken over by Oceania Equity Investments as trustee of the Oceania Trust,

So I expect the earnings to grow from here in 2024.

Should be able to adjust the fees up ect & Grow the clinic footprint.

Are the earnings back on track from here?

6039bcf5c874384930d09f143b65181e14d3c8.png



Return (inc div)   1yr: 25.73%   3yr: 19.08% pa   5yr: 5.53% pa

MVF share price down on announcement today. Down 9%

3cbb6de18871545b5704188732779f3f39597b.png

Read More
#2023 AGM - Presentation
stale
Added one year ago

38.0% Clinical pregnancy rate per embryo transferred in CY22 (women aged <43 years) compared to 32.6% in CY18; this increased to 38.7% in Q1 CY23;

Further progress in South-East Asia growth strategy. 

Not much on ESG here vs what the big 4 banks have to be grilled on.lol

Have the scientist studied the environmental impact of the industry?


3b9e247f43491dc7adf46c90f5c9d0c08dba00.pngb154f4151b981dacda57667ec2035b22aa468c.png

4b774f82a8767be27de93a9cd83804d7d1ed62.png

929b87c972d8f9daeca83955c13867bd3a4c46.png


Return (inc div)   1yr: 33.16%   3yr: 25.71% pa   5yr: 11.10% pa

f8c34d5be7d8e5507d99a54078fd262964ca4a.png

Read More
#Report FY 2023
stale
Added one year ago

Monash IVF Group spent $12.7m on business acquisitions in FY23. The ART Associates QLD acquisition was completed in late September 2023, delivering strong market share gains in Queensland in FY23. The PIVET acquisition was completed in late May 2023 with clinics in Perth and Cairns, resulting in Monash IVF Group having true national mainland presence.

Despite the major investments we have made in future growth across our businesses in recent years, our balance sheet remains in a strong position. Net debt was $31.0m as at 30 June 2023 and balance sheet capacity remains strong to fund domestic and South East Asia market growth where Monash IVF Group is under-represented. In closing,

I would like to thank our People and Clinicians for their hard work and dedication, and to thank you, our shareholders, for your continuing support.

We are energised about the journey ahead for Monash IVF Group, as we move closer to achieving our strategic objectives. Malik Jainudeen Chief Financial Officer & Company Secretary

MONASH IVF GROUP LIMITED (ASX:MVF) - Ann: FY2023 Annual Report to Shareholders, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum

f8491e09c3167602e9edf71634e10b22366116.png

bc5a1fcb52b80eb08012933c16c3a256bbd8ca.png


ef4cf8c42d00458629fef681288ec7892fa230.png


Almost a 52 week

Return (inc div)   1yr: 48.13%   3yr: 37.89% pa   5yr: 14.00% pa

e3724a5f9951e2665fdb086df099521f8af7ba.png

a994a58421e8f04a2a9c72c2ee2845d8e5aba8.png

a3f820aa76f21022cabe0b7698f7e1c4acc694.png


Read More
#Bear Case
stale
Added 3 years ago

From the ABC today, regarding Monash's class action. In sum, the non-invasive embryo viability test touted as accurate as an invasive test found to have been untrue. Class action to come.

https://www.abc.net.au/news/2022-04-23/monash-ivf-group-faulty-genetic-test-class-action-compensation/101005352

Read More